Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.

Zhang, Haoqian; Chang, Mayland; Hansen, Christopher N.; Basso, D. Michele; Noble-Haeusslein, Linda J.

doi:10.1007/s13311-011-0038-0

Cited by 164Spinal Cord Injury ResearchProtease and Inhibitor MechanismsNerve injury and regeneration

The DOI matches its Crossref record; 102 of the 105 references it cites were found in a registry or an index.

Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.

Open access

Zhang, Haoqian, Chang, Mayland, Hansen, Christopher N., Basso, D. Michele, Noble-Haeusslein, Linda J.·2011·Neurotherapeutics

DOI 10.1007/s13311-011-0038-0PMC PMC3077748

Open this paper in CoChat — free account Open PDF

Abstract

This review will focus on matrix metalloproteinases (MMPs) and their inhibitors in the context of spinal cord injury (SCI). MMPs have a specific cellular and temporal pattern of expression in the injured spinal cord. Here we consider their diverse functions in the acutely injured cord and during wound healing. Excessive activity of MMPs, and in particular gelatinase B (MMP-9), in the acutely injured cord contributes to disruption of the blood-spinal cord barrier, and the influx of leukocytes into the injured cord, as well as apoptosis. MMP-9 and MMP-2 regulate inflammation and neuropathic pain after peripheral nerve injury and may contribute to SCI-induced pain. Early pharmacologic inhibition of MMPs or the gelatinases (MMP-2 and MMP-9) results in an improvement in long-term neurological recovery and is associated with reduced glial scarring and neuropathic pain. During wound healing, gelatinase A (MMP-2) plays a critical role in limiting the formation of an inhibitory glial scar, and mice that are genetically deficient in this protease showed impaired recovery. Together, these findings illustrate complex, temporally distinct roles of MMPs in SCIs. As early gelatinase activity is detrimental, there is an emerging interest in developing gelatinase-targeted therapeutics that would be specifically tailored to the acute injured spinal cord. Thus, we focus this review on the development of selective gelatinase inhibitors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s13311-011-0038-0

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

MMP-9 may be responsible for ECM reorganization after CNS injury and stroke.
“MMP-9 may be responsible for this ECM reorganization”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Zhang et al., 2011
Increased MMP-9 levels have been demonstrated following CNS injury and stroke in humans as well as animal models.
“a number of studies have demonstrated increased MMP-9 levels following CNS injury and stroke in humans as well as animal models (Zhang et al., 2011; Chaturvedi and Kaczmarek, 2014; Liu et al., 2014).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Zhang et al., 2011
Transcripts from MMP-9, 3, 7, and 14 are upregulated in rodent models of spinal cord injury.
“Quantitative PCR analysis indicates that transcripts from MMP-9, 3, 7, and 14 are upregulated in rodent models of spinal cord injury (Zhang et al., 2011).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Zhang et al., 2011

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage
Guo, Z., Sun, X., He, Z., Jiang, Y. Q., Zhang, X., & Zhang, J. H. (2009) · Neurological Research · doi:10.1179/016164109x12478302362491 · Cited by 59
Retracted
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1326 · Cited by 3,151
Matrix metalloproteinases and the regulation of tissue remodelling
Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1821 · Cited by 1,239
Metalloproteinases in biology and pathology of the nervous system
Yong, W. V., Power, C., Forsyth, P., & Edwards, D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,094
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury
Siddall, P. J., McClelland, J. M., Rutkowski, S. B., & Cousins, M. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00452-9 · Cited by 968
Tetracyclines: Nonantibiotic properties and their clinical implications
Sapadin, A. N., & Fleischmajer, R. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.004 · Cited by 771
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain
Kawasaki, Y., Xu, Z., Wang, X., Park, J. Y., Zhuang, Z., Tan, P.-H., Gao, Y., Roy, K., Corfas, G., Lo, E. H., et al. (2008) · Nature Medicine · doi:10.1038/nm1723 · Cited by 759
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
Boissier, S., Ferreras, M., Peyruchaud, O., Magnetto, S., Ebetino, F. H., Colombel, M. C., Delmas, P. D., Delaissé, J., & Clézardin, P. (2000) · PubMed · Cited by 573
The Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events
Noble‐Haeusslein, L. J., Donovan, F. M., Igarashi, T., Goussev, S., & Werb, Z. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07526.2002 · Cited by 502
Self-citation
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice.
Shipley, J. M., Wesselschmidt, R. L., Kobayashi, D. K., Ley, T. J., & Shapiro, S. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3942 · Cited by 502
NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors
Jones, L. L., Yamaguchi, Y., Stallcup, W. B., & Tuszynski, M. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02792.2002 · Cited by 482
Minocycline and Neurodegenerative Diseases
Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447
A Highly Specific Inhibitor of Matrix Metalloproteinase-9 Rescues Laminin from Proteolysis and Neurons from Apoptosis in Transient Focal Cerebral Ischemia
Gu, Z., Cui, J., Brown, S., Fridman, R. A., Mobashery, S., Strongin, A. Y., & Lipton, S. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1563-05.2005 · Cited by 420
Sodium Channels and Mechanisms of Neuropathic Pain
Devor, M. G. (2006) · Journal of Pain · doi:10.1016/j.jpain.2005.09.006 · Cited by 401
Matrix Metalloproteinase Inhibitor Development and the Remodeling of Drug Discovery
Peterson, J. T. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011395.11179.af · Cited by 373
Macrophage-Derived Matrix Metalloproteinase-2 and -9 Promote the Progression of Cerebral Aneurysms in Rats
Aoki, T., Kataoka, H., Morimoto, M., Nozaki, K., & Hashimoto, N. (2006) · Stroke · doi:10.1161/01.str.0000252129.18605.c8 · Cited by 358
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
Rosenberg, G. A., & Yang, Y. R. (2007) · Neurosurgical FOCUS · doi:10.3171/foc.2007.22.5.5 · Cited by 358
Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood–brain barrier dysfunction
Haorah, J., Ramirez, S. H., Schall, K. A., Smith, D. L., Pandya, R., & Persidsky, Y. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04393.x · Cited by 334
To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition
Jacobsen, J. A., Jourden, J. L. M., Miller, M. T., & Cohen, S. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 327
Matrix metalloproteinases degrade myelin basic protein
Chandler, S., Coates, R. E., Gearing, A. J. H., Lury, J., Wells, G., & Bone, E. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12173-0 · Cited by 294
Blood‐spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing
Whetstone, W. D., Hsu, J. C., Eisenberg, M., Werb, Z., & Noble‐Haeusslein, L. J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10759 · Cited by 288
Self-citation
Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells
Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., & Okada, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6691 · Cited by 286
Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid Derivatives
Tamura, Y., Watanabe, F., Nakatani, T., Yasui, K., Fuji, M., Komurasaki, T., Tsuzuki, H., Maekawa, R., Yoshioka, T., Kawada, K., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9707582 · Cited by 286
Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats
Detloff, M. R., Fisher, L. C., McGaughy, V., Longbrake, E. E., Popovich, P. G., & Basso, D. M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.009 · Cited by 278
Self-citation
Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids
Grobelny, D. W., Poncz, L., & Galardy, R. E. (1992) · Biochemistry · doi:10.1021/bi00146a017 · Cited by 274
Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury
Hsu, J.-Y. C., McKeon, R. J., Goussev, S., Werb, Z., Lee, J.-U., Trivedi, A. A., & Noble‐Haeusslein, L. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1993-06.2006 · Cited by 238
Self-citation
MMPs in the central nervous system: Where the good guys go bad
AGRAWAL, S., LAU, L., & Yong, V. W. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.06.003 · Cited by 226
Effect of cytokines on neuronal excitability
Schäfers, M., & Sorkin, L. S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.052 · Cited by 225
Overcoming Macrophage-Mediated Axonal Dieback Following CNS Injury
Busch, S. A., Horn, K. P., Silver, D. J., & Silver, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1151-09.2009 · Cited by 217
Multiphasic roles for matrix metalloproteinases after stroke
ROSELL, A., & LO, E. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.001 · Cited by 215
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice
Wells, J. E. A., Rice, T. K., Nuttall, R. K., Edwards, D. R., Zekki, H., Rivest, S., & Yong, V. W. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-31-10107.2003 · Cited by 203
MMP Inhibition and Downregulation by Bisphosphonates
Teronen, O. P., Heikkilä, P., Konttinen, Y. T., Laitinen, M., Salo, T. A., Hanemaaijer, R., TERONEN, A., Maisi, P. S., & Sorsa, T. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07702.x · Cited by 200
Potent and Selective Mechanism-Based Inhibition of Gelatinases
Brown, S., Bernardo, M. M., Li, Z., Kotra, L. P., Tanaka, Y., Fridman, R. A., & Mobashery, S. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001461n · Cited by 198
Matrix Metalloproteinase Inhibitors
Dormán, G., Cseh, S., Hajdú, I., Barna, L., Konya, D., Kupai, K., Kovács, L., & Ferdinándy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 180
Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation*
Alexander, J. S., & Elrod, J. W. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00057.x · Cited by 179
Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3
Cowell, S., Knäuper, V., STEWART, M. L., d’Ortho, M., Stanton, H., Hembry, R. M., López-Otı́n, C., Reynolds, J. J., & Murphy, G. (1998) · Biochemical Journal · doi:10.1042/bj3310453 · Cited by 173
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non‐antimicrobial tetracycline analog (COL‐3) in a metastatic prostate cancer model
Lokeshwar, B. L., Selzer, M. G., Zhu, B., Block, N. L., & Golub, L. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.10168 · Cited by 161
Dengue‐virus‐infected dendritic cells trigger vascular leakage through metalloproteinase overproduction
Luplerdlop, N., Missé, D., Bray, D. H., Deleuze, V., Gonzalez, J., Leardkamolkarn, V., Yssel, H., & Veas, F. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400814 · Cited by 154
Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor
Maquoi, E., Sounni, N. E., Devy, L., Olivier, F., Frankenne, F., Krell, H., Grams, F., Foidart, J., & Noël, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0125 · Cited by 152
Matrix Metalloproteinase-9 Facilitates Glial Scar Formation in the Injured Spinal Cord
Hsu, J.-Y. C., Bourguignon, L., Adams, C. M., Peyrollier, K., Zhang, H. M., Fandel, T. M., Cun, C. L., Werb, Z., & Noble‐Haeusslein, L. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2287-08.2008 · Cited by 150
Self-citation
Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve
Chattopadhyay, S., Myers, R. R., Janes, J. R., & Shubayev, V. I. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.10.015 · Cited by 142
Diapedesis of monocytes is associated with MMP‐ mediated occludin disappearance in brain endothelial cells
Reijerkerk, A., Kooij, G., van der Pol, S. M. A., Khazen, S., Dijkstra, C. D., & de Vries, H. E. (2006) · The FASEB Journal · doi:10.1096/fj.06-6099fje · Cited by 140
Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
Botos, I., Scapozza, L., Zhang, D., Liotta, L. A., & Meyer, E. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2749 · Cited by 138
Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2
Tóth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z., Bigg, H. F., Overall, C. M., DeClerck, Y. A., Tschesche, H., Cher, M. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006871200 · Cited by 134
Erratum To: Dengue‐virus‐infected dendritic cells trigger vascular leakage through metalloproteinase overproduction
Luplertlop, N., Missé, D., Bray, D. H., Deleuze, V., Gonzalez, J., Leardkamolkarn, V., Yssel, H., & Veas, F. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400868 · Cited by 134
The TIMPs tango with MMPs and more in the central nervous system
Crocker, S. J., Pagenstecher, A., & Campbell, I. L. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10836 · Cited by 134
Induction of MMP-9 Expression and Endothelial Injury by Oxidative Stress after Spinal Cord Injury
Yu, F., Kamada, H., Niizuma, K., Endo, H., & Chan, P. H. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0438 · Cited by 133
Dopamine Receptor Modulation of Hypoxic—Ischemic Neuronal Injury in Striatum of Newborn Piglets
Yang, Z.-J., Torbey, M., Li, X., Bernardy, J., Golden, W. C., Martin, L. J., & Koehler, R. C. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600440 · Cited by 127
Cellular activation of proMMP‐13 by MT1‐MMP depends on the C‐terminal domain of MMP‐13
Knäuper, V., BAILEY, L., Worley, J. R., Soloway, P. D., Patterson, M. L., & Murphy, G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03654-2 · Cited by 123
MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage
Kobayashi, H., Chattopadhyay, S., Kato, K., Dolkas, J., Kikuchi, S., Myers, R. R., & Shubayev, V. I. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.08.008 · Cited by 116
Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release
Sugawara, T., Lewén, A., Gasche, Y. G., Yu, F., & Chan, P. H. (2002) · The FASEB Journal · doi:10.1096/fj.02-0251fje · Cited by 116
Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury
Xu, J., Kim, G.-M., Ahmed, S. H., Xu, J., Yan, P., Xu, X., & Hsu, C. Y. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00092.2001 · Cited by 113
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Naglich, J. G., Jure‐Kunkel, M., Gupta, E., Fargnoli, J., Henderson, A. J., Lewin, A. C., Talbott, R. L., Baxter, A., Bird, J., Savopoulos, R., et al. (2001) · PubMed · Cited by 110
Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines
Heikkilä, P., Teronen, O. P., Moilanen, M., Konttinen, Y. T., Hanemaaijer, R., Laitinen, M., Maisi, P. S., van der Pluijm, G., Bartlett, J. D., Salo, T. A., et al. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200203000-00006 · Cited by 109
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
Gatto, C., Rieppi, M., Borsotti, P., Innocenti, S., Ceruti, R., Drudis, T., Scanziani, E., Casazza, A. M., Taraboletti, G., & Giavazzi, R. (1999) · PubMed · Cited by 107
Phenoxyphenyl Sulfone N -Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors
Wada, C. K., Holms, J. H., Curtin, M. L., Dai, Y., Florjancic, A. S., Garland, R. B., Guo, Y. P., Heyman, H. R., Stacey, J. R., Steinman, D. H., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0103920 · Cited by 106
Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease
Becker, D. P., Barta, T. E., Bedell, L. J., Boehm, T. L., Bond, B. R., Carroll, J. N., Carron, C. P., DeCrescenzo, G. A., Easton, A. M., Freskos, J. N., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100669j · Cited by 101
MMP-Related Gelatinase Activity Is Strongly Induced in Scar Tissue of Injured Adult Spinal Cord and Forms Pathways for Ingrowing Neurites
Duchossoy, Y., Horvat, J.-C., & Stettler, O. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.0986 · Cited by 99
Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)
Kim, S., Pudzianowski, A. T., Leavitt, K. J., Barbosa, J., McDonnell, P. A., Metzler, W. J., Rankin, B. M., Liu, R., Vaccaro, W. D., & Pitts, W. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.016 · Cited by 96
Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing
Goussev, S., Hsu, J.-Y. C., Lin, Y., Tjoa, T., Maida, N., Werb, Z., & Noble‐Haeusslein, L. J. (2003) · Journal of Neurosurgery Spine · doi:10.3171/spi.2003.99.2.0188 · Cited by 91
Self-citation
Matrix Metalloproteinases and Neurotrauma: Evolving Roles in Injury and Reparative Processes
Zhang, H., Adwanikar, H., Werb, Z., & Noble-Haeusslein, L. J. (2010) · The Neuroscientist · doi:10.1177/1073858409355830 · Cited by 84
Self-citation
Ischemia injury alters endothelial cell properties of kidney cortex: Stimulation of MMP-9
Caron, A., Desrosiers, R. R., & Béliveau, R. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.004 · Cited by 76
Roles of Matrix Metalloproteinases in Flow-Induced Outward Vascular Remodeling
Ota, R., Kurihara, C., Tsou, T.-L., Young, W. L., Yeghiazarians, Y., Chang, M., Mobashery, S., Sakamoto, A., & Hashimoto, T. N. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.77 · Cited by 71
Self-citation
Matrix metalloproteinases and proteoglycans in axonal regeneration
Pizzi, M. A., & Crowe, M. J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.012 · Cited by 71
Metalloproteinase increases in the injured rat spinal cord
de Castro, R., Burns, C. L., McAdoo, D. J., & Romanic, A. M. (2000) · Neuroreport · doi:10.1097/00001756-200011090-00029 · Cited by 70
Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection
Romero‐Perez, D., Fricovsky, E. S., Yamasaki, K. G., Griffin, M. O., Barraza-Hidalgo, M., DILLMANN, W. H., & Villarreal, F. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.028 · Cited by 69
Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury
Veeravalli, K. K., Dasari, V. R., Tsung, A. J., Dinh, D. H., Gujrati, M., Fassett, D., & Rao, J. S. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.012 · Cited by 69
Evaluation of P1'-Diversified Phosphinic Peptides Leads to the Development of Highly Selective Inhibitors of MMP-11
Matziari, M., Beau, F., Cuniasse, P., Dive, V., & Yiotakis, A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0308491 · Cited by 67
Synthesis and Structure−Activity Relationship of α-Sulfonylhydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis
Aranapakam, V., Grosu, G. T., Davis, J. M., Hu, B., Ellingboe, J. W., Baker, J., Skotnicki, J. S., Zask, A., DiJoseph, J. F., Sung, A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205548 · Cited by 64
Targeting MMPs in Acute and Chronic Neurological Conditions
Yong, V. W., Agrawal, S. M., & Stirling, D. P. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.005 · Cited by 64
Prevention of progressive joint destruction in collagen‐induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031
Ishikawa, T., Nishigaki, F., Miyata, S., Hirayama, Y., Minoura, K., Imanishi, J., Neya, M., Mizutani, T., Imamura, Y., Naritomi, Y., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706054 · Cited by 61
Synthesis of Chiral 2-(4-Phenoxyphenylsulfonylmethyl)thiiranes as Selective Gelatinase Inhibitors
Lee, M., Bernardo, M. M., Meroueh, S. O., Brown, S., Fridman, R. A., & Mobashery, S. (2005) · Organic Letters · doi:10.1021/ol0517269 · Cited by 59
Active Site Ring‐Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases
Forbes, C. C., Shi, Q., Fisher, J. F., Lee, M., Hesek, D., Llarrull, L. I., Tóth, M., Gossing, M., Fridman, R. A., & Mobashery, S. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00881.x · Cited by 59
Osler and the "medico-chirurgical neurologists": Horsley, Cushing, and Penfield.
Feindel, W. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.1.0188 · Cited by 53
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis
Buhler, L. A., Samara, R. F., Guzmán, E. A., Wilson, C. L., Krizanac-Bengez, L., Janigro, D., & Ethell, D. W. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-17 · Cited by 52
CMT-3, a Non-antimicrobial Tetracycline (TC), Inhibits MT1-MMP Activity: Relevance to Cancer
Lee, M. K., Golub, M., Cao, J. P., Teronen, O. P., Laitinen, M., Salo, T. A., Zucker, S., & Sorsa, T. A. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373660 · Cited by 50
The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position
Levin, J. I., Du, M. T., DiJoseph, J. F., Killar, L. M., Sung, A., Walter, T., Sharr, M. A., Roth, C. E., Moy, F. J., Powers, R., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00642-9 · Cited by 45
Design, Synthesis, and Evaluation of a Mechanism-Based Inhibitor for Gelatinase A
Ikejiri, M., Bernardo, M. M., Meroueh, S. O., Brown, S., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050339+ · Cited by 41
Self-citation
Metabolism of a Highly Selective Gelatinase Inhibitor Generates Active Metabolite
Lee, M., Villegas‐Estrada, A., Celenza, G., Boggess, B., Tóth, M., Kreitinger, G., Forbes, C. C., Fridman, R. A., Mobashery, S., & Chang, M. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00577.x · Cited by 41
Self-citation
Carbamoylphosphonate Matrix Metalloproteinase Inhibitors 6: cis-2-Aminocyclohexylcarbamoylphosphonic Acid, A Novel Orally Active Antimetastatic Matrix Metalloproteinase-2 Selective Inhibitor—Synthesis and Pharmacodynamic and Pharmacokinetic Analysis
Hoffman, A., Qadri, B., Frant, J., Katz, Y., Bhusare, S. R., Breuer, E., Hadar, R., & Reich, R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701087n · Cited by 41
Inhibition of MMP2/MMP9 After Spinal Cord Trauma Reduces Apoptosis
Dang, A. B. C., Tay, B. K.-B., Kim, H. T., Nauth, A., Alfonso-Jaume, M., & Lovett, D. H. (2008) · Spine · doi:10.1097/brs.0b013e31817ecc87 · Cited by 40
Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors
Testero, S. A., Lee, M., Staran, R. T., Espahbodi, M., Llarrull, L. I., Tóth, M., Mobashery, S., & Chang, M. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100254e · Cited by 38
Self-citation
A Potent Gelatinase Inhibitor with Anti‐Tumor‐Invasive Activity and its Metabolic Disposition
Lee, M., Celenza, G., Boggess, B., Blase, J. R., Shi, Q., Tóth, M., Bernardo, M. M., Wolter, W. R., Suckow, M. A., Hesek, D., et al. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00750.x · Cited by 34
Self-citation
Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3
Reiter, L. A., Mitchell, P. G., Martinelli, G. J., Lopresti‐Morrow, L., Yocum, S. A., & Eskra, J. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00413-x · Cited by 34
Benzodiazepine inhibitors of the MMPs and TACE
Nelson, F. C., Santos, E. D., Levin, J. I., Chen, J., Skotnicki, J. S., DiJoseph, J. F., Sharr, M. A., Sung, A., Killar, L. M., Cowling, R. A., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00633-9 · Cited by 33
Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors
Zhang, L., Zhang, J., Fang, H., Wang, Q., & Xu, W. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.015 · Cited by 26
Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors
Cheng, X., Wang, Q., Fang, H., Tang, W., & Xu, W. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.027 · Cited by 26
Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective α-sulfone hydroxamates
Kolodziej, S. A., Hockerman, S. L., Boehm, T. L., Carroll, J. N., DeCrescenzo, G. A., McDonald, J. J., Mischke, D. A., Munie, G. E., Fletcher, T., Rico, J. G., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.130 · Cited by 22
Effects of matrix metalloproteinase 9 inhibition on the blood brain barrier and inflammation in rats following cardiopulmonary resuscitation.
He, Z., Huang, Z., Chen, X.-T., & Zou, Z. (2009) · PubMed · Cited by 21
β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 2. Optimization of α-amino substituents
Yang, S., Scannevin, R. H., Wang, B., Burke, S. L., Huang, Z., Karnachi, P., Wilson, L. J., Rhodes, K. J., Lagu, B. R., & Murray, W. V. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.129 · Cited by 21
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases
Levin, J. I., Gu, Y., Nelson, F. C., Zask, A., DiJoseph, J. F., Sharr, M. A., Sung, A., Jin, G., Cowling, R. A., Chanda, P. K., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00644-2 · Cited by 20
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770
Curtin, M. L., Florjancic, A. S., Heyman, H. R., Michaelides, M. R., Garland, R. B., Holms, J. H., Steinman, D. H., Dellaria, J. F., Gong, J., Wada, C. K., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00032-4 · Cited by 20
Synthesis, Kinetic Characterization and Metabolism of Diastereomeric 2‐(1‐(4‐Phenoxyphenylsulfonyl)ethyl)thiiranes as Potent Gelatinase and MT1‐MMP Inhibitors
Gooyit, M., Lee, M., Hesek, D., Boggess, B., Oliver, A. G., Fridman, R. A., Mobashery, S., & Chang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00898.x · Cited by 17
Self-citation
5-Carboxylate Substituted Piperazine-2-ones as Potent and Selective MMP-2 Inhibitors
Chung, Y.-J. (2008) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2008.29.6.1103 · Cited by 3

Flagged first, then by citations

3 of the 105 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Trivedi, 2005, The effects of acute and extended inhibition of matrix metalloproteinases on demyelination and functional recovery after spinal cord injury, Int J Neuroprotect Neuroregen, 2, 30

Sorted by citations

MMP ‐9 in translation: from molecule to brain physiology, pathology, and therapy
Vafadari, B., Salamian, A., & Kaczmarek, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 393
Restoring function after spinal cord injury: towards clinical translation of experimental strategies
Ramer, L. M., Ramer, M. S., & Bradbury, E. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70144-9 · Cited by 330
An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling
Hong, L. T. A., Kim, Y., Park, H. H., Hwang, D. H., Cui, Y., Lee, E. M., Yahn, S. L., Lee, J. K., Song, S., & Kim, B. G. (2017) · Nature Communications · doi:10.1038/s41467-017-00583-8 · Cited by 254
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
Acute complications of spinal cord injuries
Hagen, E. M. (2015) · World Journal of Orthopedics · doi:10.5312/wjo.v6.i1.17 · Cited by 228
Extracellular matrix regulation of inflammation in the healthy and injured spinal cord
Gaudet, A. D., & Popovich, P. G. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.020 · Cited by 227
The glial scar in spinal cord injury and repair
Yuan, Y., & He, C. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1358-3 · Cited by 213
Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy
Gao, M., Nguyen, T. T., Suckow, M. A., Wolter, W. R., Gooyit, M., Mobashery, S., & Chang, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517847112 · Cited by 179
Self-citation
The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00270 · Cited by 170
Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury
Zhong, Y., & Shultz, R. B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206633 · Cited by 165
Review: Manipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair
Burnside, E. R., & Bradbury, E. J. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12114 · Cited by 160
Preclinical Safety of Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Supporting Clinical Trials in Spinal Cord Injury
Priest, C. A., Manley, N. C., Denham, J., Wirth, E. D., & LEBKOWSKI, J. S. (2015) · Regenerative Medicine · doi:10.2217/rme.15.57 · Cited by 123
Engineered Multifunctional Zinc–Organic Framework-Based Aggregation-Induced Emission Nanozyme for Accelerating Spinal Cord Injury Recovery
Zheng, J., Chen, T., Wang, K., Peng, C., Zhao, M., Xie, Q., Li, B., Lin, H., Zhao, Z., Ji, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c10541 · Cited by 122
Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury
Dyck, S. M., Kataria, H., Alizadeh, A., Santhosh, K. T., Lang, B. T., Silver, J., & Karimi‐Abdolrezaee, S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1128-2 · Cited by 114
Neuroinflammatory contributions to pain after SCI: Roles for central glial mechanisms and nociceptor-mediated host defense
Walters, E. T. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.02.001 · Cited by 106
Matrix Metalloproteinase-8 Plays a Pivotal Role in Neuroinflammation by Modulating TNF-α Activation
Lee, E.-J., Han, J. E., Woo, M.-S., Shin, J. A., Park, E., Kang, J. L., Moon, P. G., Baek, M., Son, W.-S., Ko, Y. T., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303240 · Cited by 90
Emerging Concepts in Myeloid Cell Biology after Spinal Cord Injury
Hawthorne, A. L., & Popovich, P. G. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0032-6 · Cited by 94
Overcoming neurite‐inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix
Cua, R. C., Lau, L. W., Keough, M. B., Midha, R., Apte, S., & Yong, V. W. (2013) · Glia · doi:10.1002/glia.22489 · Cited by 90
Molecular insights and novel approaches for targeting tumor metastasis
Das, S. S., Alkahtani, S. H., Bharadwaj, P., Ansari, M. T., Alkahtani, M. D. F., Pang, Z., Hasnain, M. S., Nayak, A. K., & Aminabhavi, T. M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119556 · Cited by 85
Concise Review: Spinal Cord Injuries: How Could Adult Mesenchymal and Neural Crest Stem Cells Take Up the Challenge?
Neirinckx, V., Cantinieaux, D., Coste, C., Rogister, B., Franzen, R., & Wislet‐Gendebien, S. (2013) · Stem Cells · doi:10.1002/stem.1579 · Cited by 84
A novel Drosophila injury model reveals severed axons are cleared through a Draper/MMP-1 signaling cascade
Purice, M. D., Ray, A., Muenzel, E. J., Pope, B. J., Park, D. J., Speese, S. D., & Logan, M. A. (2017) · eLife · doi:10.7554/elife.23611 · Cited by 75
Matrix Metalloproteinases in Neuropathic Pain and Migraine: Friends, Enemies, and Therapeutic Targets
Lakhan, S. E., & Avramut, M. (2012) · Pain Research and Treatment · doi:10.1155/2012/952906 · Cited by 67
Elevated MMP-9 in the Lumbar Cord Early after Thoracic Spinal Cord Injury Impedes Motor Relearning in Mice
Hansen, C. N., Fisher, L. C., Deibert, R. J., Jakeman, L. B., Zhang, H., Noble‐Haeusslein, L. J., White, S. R., & Basso, D. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1576-13.2013 · Cited by 68
Self-citation
Management strategies for acute spinal cord injury
Stahel, P. F., VanderHeiden, T. F., & Finn, M. A. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32835a0e54 · Cited by 66
Extracellular Matrix and Oxidative Stress Following Traumatic Spinal Cord Injury: Physiological and Pathophysiological Roles and Opportunities for Therapeutic Intervention
Chio, J. C. T., Punjani, N., Hejrati, N., Zavvarian, M.-M., Hong, J., & Fehlings, M. G. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0120 · Cited by 67
Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier
Chaturvedi, M., Molino, Y., Sreedhar, B., Khrestchatisky, M., & Kaczmarek, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54750 · Cited by 65
Exogenous BDNF enhances the integration of chronically injured axons that regenerate through a peripheral nerve grafted into a chondroitinase-treated spinal cord injury site
Tom, V. J., Sandrow-Feinberg, H. R., Miller, K., Domitrovich, C., Bouyer, J., Zhukareva, V. A., Klaw, M. C., Lemay, M. A., & Houlé, J. D. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.011 · Cited by 65
Regulation of Caveolin-1 and Junction Proteins by bFGF Contributes to the Integrity of Blood–Spinal Cord Barrier and Functional Recovery
Ye, L.-B., Yu, X., Xia, Q.-H., Yang, Y., Chen, D., Wu, F., Wei, X., Zhang, X., Zheng, B., Fu, X., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0437-3 · Cited by 61
Self-citation
Stem Cells in Canine Spinal Cord Injury – Promise for Regenerative Therapy in a Large Animal Model of Human Disease
McMahill, B. G., Borjesson, D. L., Sieber‐Blum, M., Nolta, J. A., & Sturges, B. K. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9553-9 · Cited by 50
Neutrophil, Extracellular Matrix Components, and Their Interlinked Action in Promoting Secondary Pathogenesis After Spinal Cord Injury
Dolma, S., & Kumar, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02443-5 · Cited by 48
Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain
Kuhad, A., Singh, P., & Chopra, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.960844 · Cited by 43
Pathological hemodynamic changes and leukocyte transmigration disrupt the blood–spinal cord barrier after spinal cord injury
Zhou, R., Li, J., Chen, Z., Wang, R., Shen, Y., Zhang, R., Zhou, F., & Zhang, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02787-w · Cited by 41
The dual role of microglia in neuropathic pain after spinal cord injury: Detrimental and protective effects
Sun, C., Deng, J., Ma, Y., Meng, F., Cui, X., Li, M., Li, J., Li, J., Yin, P., Kong, L., et al. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114570 · Cited by 43
Expression Levels of Matrix Metalloproteinase-9 and Gram-negative Bacteria in Symptomatic and Asymptomatic Periapical Lesions
Ahmed, G., Elbaz, P. D. A. A., Hashem, A. A. R., & Shalaan, A. K. (2013) · Journal of Endodontics · doi:10.1016/j.joen.2012.11.009 · Cited by 41
ADAM10–Notch signaling governs the recruitment of ovarian pregranulosa cells and controls folliculogenesis in mice
Feng, L., Wang, Y., Cai, H., Sun, G., Niu, W., Xin, Q., Tang, X., Zhang, J., Wang, C., Zhang, H., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.184267 · Cited by 41
Self-citation
Spatio‐Temporal Development of Axonopathy in Canine Intervertebral Disc Disease as a Translational Large Animal Model for Nonexperimental Spinal Cord Injury
Bock, P., Spitzbarth, I., Haist, V., Stein, V. M., Tipold, A., Puff, C., Beineke, A., & Baumgärtner, W. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00617.x · Cited by 40
Meta-Analysis of MMP2, MMP3, and MMP9 Promoter Polymorphisms and Head and Neck Cancer Risk
Zhang, C., Li, C., Zhu, M., Zhang, Q., Xie, Z., Niu, G., Song, X., Jin, L., Li, G., & Zheng, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062023 · Cited by 39
Molecular and Cellular Changes in the Lumbar Spinal Cord following Thoracic Injury: Regulation by Treadmill Locomotor Training
Shin, H. Y., Kim, H., Kwon, M. J., Hwang, D. H., Lee, K., & Kim, B. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088215 · Cited by 39
Intrathecal administration of naringenin improves motor dysfunction and neuropathic pain following compression spinal cord injury in rats: relevance to its antioxidant and anti-inflammatory activities
Fakhri, S., Sabouri, S., Kiani, A., Farzaei, M. H., Rashidi, K., Mohammadi-Farani, A., Noori, E. M., & Abbaszadeh, F. (2022) · The Korean journal of pain · doi:10.3344/kjp.2022.35.3.291 · Cited by 38
Effects of combining methylprednisolone with rolipram on functional recovery in adult rats following spinal cord injury
Yin, Y., Sun, W., Li, Z., Zhang, B., Cui, H., Deng, L., Xie, P., Xiang, J., & Zou, J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.03.005 · Cited by 37
Voluntary wheel running preserves lumbar perineuronal nets, enhances motor functions and prevents hyperreflexia after spinal cord injury
Sánchez-Ventura, J., Giménez‐Llort, L., Penas, C., & Udina, E. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113533 · Cited by 38
Folic Acid Modulates Matrix Metalloproteinase-2 Expression, Alleviates Neuropathic Pain, and Improves Functional Recovery in Spinal Cord-Injured Rats
Miranpuri, G. S., Meethal, S. V., Sampene, E., Chopra, A., Buttar, S., Nacht, C. L., Morales, N. M., Patel, K., Liu, L., Singh, A., et al. (2017) · Annals of Neurosciences · doi:10.1159/000475896 · Cited by 36
Kallikrein Cascades in Traumatic Spinal Cord Injury: In Vitro Evidence for Roles in Axonopathy and Neuron Degeneration
Radulovic, M., Yoon, H., Larson, N., Wu, J., Linbo, R., Burda, J. E., Diamandis, E. P., Blaber, S. I., Blaber, M., Fehlings, M. G., et al. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000007 · Cited by 36
Current Insights Into the Pathology of Canine Intervertebral Disc Extrusion-Induced Spinal Cord Injury
Spitzbarth, I., Moore, S. A., Stein, V. M., Levine, J. M., Kühl, B., Gerhauser, I., & Baumgärtner, W. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.595796 · Cited by 34
Selective Inhibitors of Medium-Size S1′ Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery
Baidya, S. K., Banerjee, S., Adhikari, N., & Jha, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01855 · Cited by 36
Efficacy of a Metalloproteinase Inhibitor in Spinal Cord Injured Dogs
Levine, J. M., Cohen, N. D., Heller, M. J., Fajt, V. R., Levine, G. J., Kerwin, S. C., Trivedi, A. A., Fandel, T. M., Werb, Z., Modestino, A. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096408 · Cited by 33
Self-citation
Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury
Moghaddam, A., Heller, R. A., Daniel, V., Swing, T., Akbar, M., Gerner, H., & Biglari, B. (2016) · Spinal Cord · doi:10.1038/sc.2016.104 · Cited by 33
Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles
Chaturvedi, M., Figiel, I., Sreedhar, B., & Kaczmarek, L. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.023 · Cited by 33
Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease
Meisel, J. E., & Chang, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.011 · Cited by 32
Self-citation
The neurovascular unit in healthy and injured spinal cord
Zhou, R., Li, J., Wang, R., Chen, Z., & Zhou, F. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231172008 · Cited by 31
On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review
Fakhri, S., Abbaszadeh, F., & Jorjani, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111563 · Cited by 30
The immune microenvironment and tissue engineering strategies for spinal cord regeneration
Yuan, F., Peng, Y., Jie, J., Yang, Y., & Yang, P. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.969002 · Cited by 28
Uridine 5′-Triphosphate Promotes In Vitro Schwannoma Cell Migration through Matrix Metalloproteinase-2 Activation
Lamarca, A., Gella, A., Martiáñez, T., Segura, M., Figueiro‐Silva, J., Grijota-Martínez, C., Trullás, R., & Casals, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098998 · Cited by 27
Peptides and Astroglia Improve the Regenerative Capacity of Alginate Gels in the Injured Spinal Cord
Schackel, T., Kumar, P., Günther, M. I., Liu, S., Brunner, M., Sandner, B., Puttagunta, R., Müller, R., Weidner, N., & Blesch, A. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2018.0082 · Cited by 27
Mesenchymal Stem Cell Transplantation Promotes Functional Recovery through MMP2/STAT3 Related Astrogliosis after Spinal Cord Injury
Kim, C., Kim, H. J., Lee, H. J., Lee, H., Lee, S. J., Lee, S. T., Yang, S., & Chung, C. K. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc18133 · Cited by 26
The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress
Ferreira‐Junior, N. C., Pereira, M. D. S., Francis, N., Ramírez, P., Martorell, P., González‐Lizárraga, F., Figadère, B., Chehín, R. N., Bel, E. A. D., Raisman‐Vozari, R., et al. (2021) · Cells · doi:10.3390/cells10082163 · Cited by 27
Folic Acid Modulates Matrix Metalloproteinase-9 Expression Following Spinal Cord Injury
Miranpuri, G. S., Nguyen, J., Morales, N. M., Yutuc, N., Kim, J., Buttar, S., Brown, G. R., Sauer, S. E., Singh, C. K., Kumar, S., et al. (2019) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.260205 · Cited by 25
Biomimetic “Trojan Horse” Fibers Modulate Innate Immunity Cascades for Nerve Regeneration
Wu, J., Tang, J., Zhang, L., Wang, W., Li, Z., Zhou, L., Jiang, X., Huang, Y., Guo, Q., Wang, W., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c12036 · Cited by 24
Rac1 Inhibition Prevents Tissue Contraction and MMP Mediated Matrix Remodeling in the Conjunctiva
Tovell, V. E., Chau, C. Y., Khaw, P. T., & Bailly, M. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8577 · Cited by 24
The Role and Modulation of Spinal Perineuronal Nets in the Healthy and Injured Spinal Cord
Sánchez-Ventura, J., Lane, M. A., & Udina, E. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.893857 · Cited by 26
Future Directions in the Treatment of Neuropathic Pain: A Review on Various Therapeutic Targets
Gangadhar, M., Mishra, R. K., Sriram, D., & Yogeeswari, P. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660192 · Cited by 25
Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System
Ganguly, K., Adhikary, K., Acharjee, A., Acharjee, P., Trigun, S. K., Mutlaq, A. S., Ashique, S., Yasmin, S., Alshahrani, A. M., & Ansari, M. Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135967 · Cited by 23
Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury
Phillips, L. L., Chan, J. L., Doperalski, A. E., & Reeves, T. M. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.128237 · Cited by 24
HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes
Baggio, C., Cerofolini, L., Fragai, M., Luchinat, C., & Pellecchia, M. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00483 · Cited by 23
Hyperbaric oxygenation treatment alleviates CCI ‐induced neuropathic pain and decreases spinal apoptosis
Hu, Q., Fang, L., Li, F., Thomas, S., & Yang, Z. (2014) · European Journal of Pain · doi:10.1002/ejp.618 · Cited by 22
Metalloproteinases 2 and 9 Immunoexpression in Periapical Lesions from Primary Endodontic Infection: Possible Relationship with the Histopathological Diagnosis and the Presence of Pain
Faustino, I. S. P., Azevedo, R. S., & Takahama, A. (2016) · Journal of Endodontics · doi:10.1016/j.joen.2015.12.020 · Cited by 22
Neuroectodermal Stem Cells Grafted into the Injured Spinal Cord Induce Both Axonal Regeneration and Morphological Restoration via Multiple Mechanisms
Pajer, K., Bellák, T., Redl, H. R., & Nógrádi, A. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.6332 · Cited by 22
The Asparaginyl Endopeptidase Legumain Is Essential for Functional Recovery after Spinal Cord Injury in Adult Zebrafish
Ma, L., Shen, Y., Khatri, H. P., & Schachner, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095098 · Cited by 22
Cytokine and chemokine profiles in women with endometriosis, polycystic ovary syndrome, and unexplained infertility
Omidvar-Mehrabadi, A., Ebrahimi, F., Shahbazi, M., & Mohammadnia‐Afrouzi, M. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156588 · Cited by 21
IL‐1β enhances cell adhesion to degraded fibronectin
Rajshankar, D., Downey, G. P., & McCulloch, C. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-207381 · Cited by 21
Bioinformatics analyses of differentially expressed genes associated with spinal cord injury: a microarray-based analysis in a mouse model
Guo, L., Lv, J., Huang, Y., Hao, D., & Liu, J. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.251335 · Cited by 21
CDP-choline modulates matrix metalloproteinases in rat sciatic injury
GÜNDOĞDU, E. B., Bekâr, A., Türkyılmaz, M., Gumus, A., Kafa, İ. M., & Cansev, M. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.10.003 · Cited by 20
Metalloproteases in Pain Generation and Persistence: A Possible Target?
Marcianò, G., Vocca, C., Rania, V., Citraro, R., Sarro, G. D., & Gallelli, L. (2023) · Biomolecules · doi:10.3390/biom13020268 · Cited by 20
Lumbar Myeloid Cell Trafficking into Locomotor Networks after Thoracic Spinal Cord Injury
Hansen, C. N., Norden, D. M., Faw, T. D., Deibert, R. J., Wohleb, E. S., Sheridan, J. F., Godbout, J. P., & Basso, D. M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.019 · Cited by 19
Self-citation
Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches
Schomberg, D. T., Miranpuri, G. S., Duellman, T., Crowell, A. D., Vemuganti, R., & Resnick, D. K. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-014-9642-0 · Cited by 20
The Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
Gopal, S. S., Kaur, M., Lanzkron, S., & Srivastava, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05592-z · Cited by 20
Vascular Pathology as a Potential Therapeutic Target in SCI
Benton, R. L., & Hagg, T. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0128-7 · Cited by 18
Elevated matrix metalloproteinase 9 supports peripheral nerve regeneration via promoting Schwann cell migration
Lu, P., Wang, G., Lu, X., Qiao, P., Jin, Y., Yu, J. J., Chen, Q., & Wang, H. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114020 · Cited by 17
Tlr4 Deletion Modulates Cytokine and Extracellular Matrix Expression in Chronic Spinal Cord Injury, Leading to Improved Secondary Damage and Functional Recovery
Ryan, F., Francos-Quijorna, I., Hernández-Mir, G., Aquino, C., Schlapbach, R., Bradbury, E. J., & David, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0778-23.2023 · Cited by 16
Downregulation of Matrix Metalloproteinases 2 and 9 is Involved in the Protective Effect of Trehalose on Spinal Cord Injury.
Mirzaie, M., Karimi, M., Fallah, H., Khaksari, M., & Nazari‐Robati, M. (2018) · Europe PMC (PubMed Central) · doi:10.22088/ijmcm.bums.7.1.8 · Cited by 16
RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders
Guha, A., Husain, M. A., Si, Y., Nabors, B., Filippova, N., Promer, G., Smith, R., & King, P. H. (2022) · Glia · doi:10.1002/glia.24288 · Cited by 16
Therapeutic administration of mouse mast cell protease 6 improves functional recovery after traumatic spinal cord injury in mice by promoting remyelination and reducing glial scar formation
Vangansewinkel, T., Lemmens, S., Tiane, A., Geurts, N., Dooley, D., Vanmierlo, T., Pejler, G., & Hendrix, S. (2023) · The FASEB Journal · doi:10.1096/fj.202201942rr · Cited by 15
Prognosticating acute traumatic spinal cord injury using Neurofilament (NF), Neuron Specific Enolase (NSE), Matrix Metalloproteinases (MMPs), and S-100B as biomarkers
Paragond, S., Dhatt, S. S., Kumar, V., Zohmangaihi, D., Gaurav, A., Neradi, D., & Pal, A. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03476-6 · Cited by 16
The acute spinal cord injury microenvironment and its impact on the homing of mesenchymal stem cells
Liu, J., Qi, L., Bao, S., Yan, F., Chen, J., Yu, S., & Dong, C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114682 · Cited by 14
Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury
Gao, M., Zhang, H. M., Trivedi, A. A., Mahasenan, K. V., Schroeder, V. A., Wolter, W. R., Suckow, M. A., Mobashery, S., Noble‐Haeusslein, L. J., & Chang, M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00217 · Cited by 14
Self-citation
Experimental treatments to attenuate blood spinal cord barrier rupture in rats with traumatic spinal cord injury: A meta-analysis and systematic review
Deng, L., Lv, J., & Sun, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950368 · Cited by 14
Matrix Metalloproteinases: New Targets in Cancer Therapy
Khalid, A., & Javaid, M. A. (2016) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000406 · Cited by 14
Overexpression of MMPs in Corneas Requiring Penetrating and Deep Anterior Lamellar Keratoplasty
Wolf, M., Clay, S. M., Oldenburg, C. E., Rose‐Nussbaumer, J., Hwang, D. G., & Chan, M. F. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25961 · Cited by 12
HDAC8 Inhibition Reduces Lesional Iba-1+ Cell Infiltration after Spinal Cord Injury without Effects on Functional Recovery
Hendrix, S., Sanchez, S., Ventriglia, E., & Lemmens, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124539 · Cited by 13
Experimental Treatments for Oedema in Spinal Cord Injury: A Systematic Review and Meta-Analysis
Masterman, E. I., & Ahmed, Z. (2021) · Cells · doi:10.3390/cells10102682 · Cited by 13
More Attention on Segments Remote from the Primary Spinal Cord Lesion Site
Chelyshev, Y. A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2708235 · Cited by 12
Matrix metalloproteinases as attractive therapeutic targets for chronic pain: A narrative review
Dai, X., Liu, L., Song, F., Gao, S., Wu, J., Li, D., Zhang, L.-Q., Liu, D.-Q., Zhou, Y., & Mei, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129619 · Cited by 12
CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery
Hong, J., Nandiwada, V., Jones, V. M., Lu, M., Warner, D. S., Mukhopadhyay, S., & Sheng, H. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.016 · Cited by 12
The preparation of rat’s acellular spinal cord scaffold and co-culture with rat’s spinal cord neuron in vitro
Ban, D.-X., Liu, Y., Cao, T.-W., Gao, S.-J., & Feng, S.-Q. (2016) · Spinal Cord · doi:10.1038/sc.2016.144 · Cited by 11
Serum Level of Metalloproteinase-2 but not Metalloproteinase-9 Rises in Patients With Failed Back Surgery Syndrome After Spinal Cord Stimulation
Kamieniak, P., Bielewicz, J., Kurzepa, J., Daniluk, B., Kocot, J., & Trojanowski, T. (2019) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12915 · Cited by 12
Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling
Gkantidis, N., Katsaros, C., & Chiquet, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0982-8 · Cited by 11
Water-Soluble MMP-9 Inhibitor Prodrug Generates Active Metabolites That Cross the Blood–Brain Barrier
Song, W., Peng, Z., Gooyit, M., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Lee, M., Ikejiri, M., Cui, J., Gu, Z., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400077d · Cited by 11
Self-citation
The correlation between hypoxia-inducible factor-1α, matrix metalloproteinase-9 and functional recovery following chronic spinal cord compression
Cheng, X., Long, H., Chen, W. K., Xu, J., Wang, X., & Fo-bao, L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.04.034 · Cited by 10
Protein post-translational modifications after spinal cord injury
Zhu, S., Yang, B.-S., Lin, L., Tong, G., Tan, J.-Y., Wu, G.-F., Li, L., Chen, G.-L., Chen, Q., & Li, L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308068 · Cited by 10
Association between systemic inflammation and experimental pain sensitivity in subjects with pain and painless neuropathy after traumatic nerve injuries
Miclescu, A. A., Granlund, P., Butler, S. H., & Gordh, T. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0195 · Cited by 9

Matrix Metalloproteinases: Potential Therapeutic Target in Spinal Cord Injury
Duchossoy, Y., Arnaud, S., & Feldblum, S. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.057 · Cited by 29
Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing
Goussev, S., Hsu, J.-Y. C., Lin, Y., Tjoa, T., Maida, N., Werb, Z., & Noble‐Haeusslein, L. J. (2003) · Journal of Neurosurgery Spine · doi:10.3171/spi.2003.99.2.0188 · Cited by 91
Self-citation
Inhibition of MMP2/MMP9 After Spinal Cord Trauma Reduces Apoptosis
Dang, A. B. C., Tay, B. K.-B., Kim, H. T., Nauth, A., Alfonso-Jaume, M., & Lovett, D. H. (2008) · Spine · doi:10.1097/brs.0b013e31817ecc87 · Cited by 40
Novel targets for Spinal Cord Injury related neuropathic pain
Ahmed, M. M., King, K. C., Pearce, S. M., Ramsey, M. A., Miranpuri, G. S., & Resnick, D. K. (2011) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.1118413 · Cited by 23
Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
Buss, A., Pech, K., Noth, J., & Brook, G. A. (2006) · Aktuelle Neurologie · doi:10.1055/s-2006-953073

Authors: Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., & Noble-Haeusslein, L. J.
Affiliations: University of California, San Francisco (US)
University of Notre Dame (US)
The Ohio State University (US)
Corresponding author: Zhang, Haoqian
ORCID: Zhang, Haoqian
Chang, Mayland
Hansen, Christopher N.
Venue: Neurotherapeutics
Publisher: Elsevier BV
Published: 2011-04
Volume: 8
Issue: 2
Pages: 206-220
ISSN: 1878-7479 (ISSN-L)
DOI: 10.1007/s13311-011-0038-0
PMC: PMC3077748
OpenAlex: W2101966356
Cited by: 163
References: 105
Citations by year: 2026: 7 · 2025: 10 · 2024: 10 · 2023: 9 · 2022: 14 · 2021: 15 · 2020: 6 · 2019: 11 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 10 · 2014: 19 · 2013: 13 · 2012: 13
FWCI: 1.98
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc/2.0/ (vor)
Locations: Neurotherapeutics (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Cancer Institute (R01CA122417)
National Institute of Neurological Disorders and Stroke (R21NS065937, R01NS050159, R01NS039278, RC1NS068200)
Topics: Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords: matrix metalloproteinases, spinal cord injury, gelatinase inhibitors, MMP-9, MMP-2, blood-spinal cord barrier, leukocyte infiltration, apoptosis, neuropathic pain, glial scar, wound healing, neurological recovery
MeSH terms: Animals, Enzyme Inhibitors, Humans, Neuralgia, Spinal Cord Injuries, Matrix Metalloproteinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks